Is imidafenacin an alternative to current antimuscarinic drugs for patients with overactive bladder syndrome?

In conclusion, imidafenacin was comparable to other ADs in the treatment of OAB. Moreover, imidafenacin presented a lower dry mouth rate, lower constipation rate and higher adherence and persistence.